Is psychiatry a scam

Psychiatry Violations Commission
against human rights Germany e.V.

Psychiatric diagnoses are categorized solely by symptoms. Psychiatrists do not use laboratory tests, blood tests, or x-rays to support their diagnosis. A blood sugar test can be used to determine if someone has diabetes. An x-ray is used for arthritis. There are no such tests for mental “disorders”.

In a study published in the US journal Psychotherapy and Psychosomatics in May 2006, it was found that pharmaceutical companies that manufacture psychotropic drugs have financially supported more than half of those psychiatrists who define such “disorders” so that they can then move into psychiatric medicine "Verrechnungsbibel", the Diagnostic and Statistical Manual of Mental Disorders (DSM). When determining the so-called “depression”, “schizophrenia” and “psychosis”, even 100% of the psychiatrists involved had undisclosed financial ties to pharmaceutical companies.

Already in SPIEGEL No. 33/2003 it says: “Financial connections, especially between psychiatrists and pharmaceutical companies, are commonplace in Germany. The German Society for Psychiatry, Psychotherapy and Neurology (DGPPN), for example, is 'supported' by companies like Astra Zeneca, Aventis Pharma Germany, Lilly, Novartis Pharma and Organon.

The US FDA warned that antidepressants can cause anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsiveness, and mania. Violence at work in the United States in recent years, including shootings, has been attributed to these psychiatric drugs.

On September 29, 2005, the Federal Institute for Drugs and Medical Devices (BfArM) published new warnings about the risk of suicide, aggressive or hostile behavior when administering "Strattera" to children. In December 2004, Strattera was approved in Germany for the treatment of children aged six and over with what is known as attention deficit / hyperactivity disorder (ADHD). By the time the warning appeared, around 10,000 children in Germany had been "treated" with Strattera.

In 2004, every day 474 people in Germany were locked into psychiatry against their will, where they can be restrained against their will and treated with electric shocks or psychotropic drugs.1

Over 100,000 patients die each year in mental hospitals around the world. According to the Federal Statistical Office, between 1993 and 2003 more than 40,900 people died in psychiatric hospitals in Germany.

Numerous empirical studies show that sexual exploitation occurs far more frequently in therapy than was generally assumed a few years ago. 10 to 12% of all male therapists state that they have “sexual relationships” with female clients.2

In an anonymous survey of nursing staff at two psychiatric hospitals in Switzerland, 16.8% of men and 10.5% of women admitted that they had sexual contact with patients.

Studies in the US show that up to 25% of psychiatrists have sex with their patients. One in 20 victims is still a minor.

20 million children worldwide are prescribed psychotropic drugs that drug regulatory agencies internationally warn that they can cause suicide, hostility, violence, mania and addiction, as well as stroke and sudden death.

At least eight out of 13 school shootings in the United States were committed by teenagers under the influence of psychiatric drugs. (The medical records on the other teenage killers are not publicly available.)

The Federal Institute for Drugs and Medical Devices (BfArM) announced on July 12, 2005 that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) came to the following conclusion in April 2005: The two antidepressants of the type of selective serotonin reuptake inhibitor Serotonin norepinephrine reuptake inhibitors (SNRI) should not be used in children and adolescents. In clinical trials, children and adolescents treated with SSRI / SNRI were more likely to experience suicidal and hostile behavior than children and adolescents treated with placebo.4

The prescriptions of antidepressants in Germany rose from 203 million daily doses in 1992 to 645 million daily doses in 2004.3

Nationwide, according to the Techniker Krankenkasse, 3.3 million people take psychotropic drugs every day. At 4.8 million euros per day, it is the third highest expenditure item in the pharmaceutical sector. Accordingly, the psychiatric industry floods our society with psychotropic drugs - for 1.75 billion euros per year. That is a multiple of what the federal government spends annually on addiction and drug prevention.4

One of the psychiatric screening programs for schools in the United States is called TeenScreen ™. The developer of the TeenScreen program, psychiatrist Dr. David Shaffer, admits that 84 teenagers may well be sent for further evaluation despite not being suicidal, while 16 teenagers are "correctly identified". This means that the test has an error rate of 84%.

France's Interior Minister Sarkozy is currently working on a law "on crime prevention", under which three-year-old children are to be subjected to regular psychiatric series tests "in order to filter out future criminals". Troublemakers should be able to cope with troublemakers from the age of six with psychopills. In most other EU countries, similar designs are already in the drawers.



  1. Federal Ministry of Justice, additional notifications from the justice and social departments of the federal states as well as supra-local supervisory authorities.
  2. Enders, 2001, p. 369.
  3. Medicinal prescription report 2002 and 2005.
  4. Federal Ministry of Health, press release of April 27, 2006.